Sputum biomarkers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011
Sputum bacterial concentrations and exacerbations of non cystic fibrosis bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008
Sputum microbiology in patients with stabile COPD Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015
Sputum proteomics of CF, BE and COPD with or without NTM infections Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021
Sputum eosinophilia in patients with chronic cough Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007
The BAL in the bacteriologic etiology in the COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005
Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD Source: Eur Respir J 2012; 40: 1344-1353 Year: 2012
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Effect of sputum bacteriology on the prognosis of patients with acute exacerbations of bronchiectasis Source: International Congress 2017 – COPD and weaning Year: 2017
Analysis of microbiological colonization in COPD patients with or without bronchiectasis Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020
Sputum colour as a marker of acute bacterial exacerbations of COPD Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations Year: 2003
Sputum neutrophilic markers in asthma of varying severity and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003
Sputum biomarkers in stable COPD Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011
Sputum bacteriology in acute COPD exacerbations: correlation with FEV1 deterioration Source: Eur Respir J 2001; 18: Suppl. 33, 189s Year: 2001
Persistent sputum eosinophilia in patients with difficult-to-treat asthma Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010
Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004
Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis Source: Eur Respir J 2009; 33: 361-364 Year: 2009
Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
Bacterial etiology of exacerbations of non-cystic fibrosis bronchiectases in young patients Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013
Pulmonary and systemic inflammation in patients with AECOPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013